BioNanovations is a biotechnology startup founded in 2012, with a mission to revolutionize diagnostics and epidemiological insights in healthcare. The company has developed a portable real-time diagnostic platform to combat the delayed diagnosis of aggressive Staph infections, significantly reducing the diagnostic time from 3-5 days to under 30 minutes. This breakthrough not only enhances diagnostic efficiency for healthcare professionals and institutions but also enables real-time monitoring of epidemiological trends. The latest investment of $40.00K in a seed round was secured on 01 September 2013 from Innova Memphis and MB Venture Partners, signifying investor confidence in BioNanovations' innovative approach. With its focus on saving lives and limbs through accelerated diagnostics, the startup holds vast potential in the biotechnology and healthcare industries.
No recent news or press coverage available for BioNanovations.